Pharmacovigilance

1,400+
Global pharmacovigilance professionals
100+
Countries
99%
Compliance with regulatory reporting timelines

Seamless and transparent pharmacovigilance solutions

A comprehensive approach to collecting and assessing product safety information is critical for the success of clinical research and the maintenance of post-marketing product licenses. Our team of over 1,000 global pharmacovigilance professionals integrates all safety services into a streamlined, transparent delivery model, providing clear, easy-to-review outputs with a strong commitment to continuous quality improvement and operational efficiency.

Assigned functional lead for clear communication routes and accountability
Industry-leading pharmacovigilance regulatory intelligence for over 100 countries
Over 99% compliance with regulatory reporting timelines
Global reach and round-the-clock coverage for clinical trials, post-marketing and medical device submissions
Cost effective high-quality case processing model
ORCA Safety
PV Affiliate Solution
Global medical information call centre services
Pharmacovigilance specialised services including safety surveillance, aggregate safety report generation, risk management solutions, literature surveillance

Safety Reporting Group

ICON’s Safety Reporting Group ensures seamless regulatory compliance and efficient safety management, supported by advanced automation and global expertise.

Risk Management and Risk Evaluation & Mitigation Strategy (REMS) Solutions

Our integrated Risk Management team forms a comprehensive risk management solution tailored to the specific nature and needs of each of our clients. Our experts provide unparalleled support in managing risks throughout a product’s lifecycle.

Ensuring patient safety

From clinical development to post-marketing

Our safety experts use advanced technologies to monitor and define the safety profile of investigational and marketed products, supporting the early detection and management of safety risks to ensure patient safety.

Safety writing solutions

Our team of safety medical writers and scientists delivers compliant, cost-effective safety writing solutions, including aggregate reports, risk management planning, and document reviews, ensuring global regulatory compliance.

Global and local literature monitoring

With more than 15 years of specialised experience, ICON delivers expert literature searches across platforms such as PubMed and Embase. We provide routine weekly monitoring and focused reviews that support periodic reporting and signal management. Our team also conducts local surveillance in line with regional requirements and reviews outputs from the European Medicines Agency medical literature monitoring programme.

Case processing

Our comprehensive case processing capabilities include receipt, data entry, narrative writing, coding, quality control, medical review, query management, and safety submissions. We process hundreds of thousands of cases, demonstrating our commitment to high-quality, efficient safety management.

Robust project documentation and management

Successful project delivery relies on comprehensive project documentation, managed by skilled project personnel. At ICON, we maintain an extensive library of SOPs and procedures governing our pharmacovigilance services to ensure thorough staff training and high-quality standards.

Each client is assigned a functional lead who oversees all activities and ensures that deliverables consistently meet defined Key Performance Indicators (KPIs).

Post-marketing pharmacovigilance

ICON understands the importance of post-marketing pharmacovigilance. Our dedicated global team manages the safety of products post-launch in the market, covering end-to-end pharmacovigilance services in the post-marketing setting including drug and medical device case processing, signal detection, literature search and review, safety writing, EU QPPV, LPPV, PSMF management, risk management support and safety regulatory intelligence consulting.

Learn more

Tailored pharmacovigilance solutions for biotech and small to mid-sized companies

At ICON, we recognise that biotech and small to mid-sized companies have distinct needs that set them apart from larger pharmaceutical firms. Our flexible, scalable, and cost-effective pharmacovigilance solutions are specifically designed to address these unique requirements. We ensure that you receive the same high level of personalised service, regardless of your organisation's size. Our pharmacovigilance solutions can be customised to meet your needs and evolve alongside your business.

Scalable and fully customisable models

Our operating models are fully flexible and can use ICON systems, sponsor systems or a combined approach. Services are available as consulting, standalone support, functional service provision, blended solutions or full service across all therapeutic areas.

ARGUS safety database

Using the Oracle ARGUS safety database, we configure a dedicated schema for each client, fully compliant with FDA 21 CFR Part 11 and supporting all standard regulatory and periodic reports. We also manage database migrations, including the transition of ongoing studies from other CROs and the seamless transfer of legacy databases.